|CD4 ALWAYS GOOD?
Apr 8, 2008
Dear Doctor, My name is Walter, brazilian, HIV positive since 1999. I had pneumonia, sinusites diharreia, but my infectologist no decide to start the haart therapy. My last exam showed 800 CD4 36.000 viral load, but my CD4 was low like 480 and 500 and viral load about 126.000. In Brazil, the consense is start with the drugs when CD4 about 300 or 200. Is it correct in your opinion?
My best wishes, Walter
Response from Dr. Frascino
Hello Brazilian Walter,
Many factors come into play when deciding when to begin antiretroviral therapy. You can read about these in the archives. Published guidelines for when to start have been revised several times over the 26-year course of the pandemic as we learned more about HIV pathogenesis and new treatments were developed and became more widely available. Most current published guidelines suggest antiretroviral therapy be started when the CD4 count falls into the 350-cell range. With the availability of newer, novel, more potent, less toxic medications, some HIV specialists are recommending starting at even higher CD4 levels.
Risk of HIV and other STDs from the various encounters
Sustiva and fatigue (SUSTIVA AND FATIGUE)
- Itchy Red Spots After Drinking After Someone Sign Of HIV AIDS
- Itchy Red Spots After Oral Sex Sign Of HIV AIDS
- Itchy Vagina After Having Sex During Period Sign Of HIV AIDS
- Rash After Deep Kissing Worried I Have HIV
- Sexually Transmitted Disease That Cause Numbness
- Burning Sensation Of Legs And Knees
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.